LeBlanc, R., Hollmann, S., & Tay, J. (2018). CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. Journal of Population Therapeutics and Clinical Pharmacology, 23(1). https://mail.jptcp.com/index.php/jptcp/article/view/237